Home Clinical Services Pharmacovigilance
Clinical Safety

Global Pharmacovigilance

Tailored safety models providing comprehensive medical monitoring and clinical safety planning.

Who We Are

Integrated Safety Model

Our safety model is tailored to the protocol, product, countries, sponsor systems, case workflow, reporting responsibilities, and required medical oversight. Globyz Clinical Solutions coordinates this service in collaboration with CEBIS USA LLC, its U.S. affiliate and clinical research arm. The teams work together within an agreed delivery model, and clinical studies are conducted through CEBIS USA.

Discuss Your Safety Requirements
Pharmacovigilance

Safety Excellence

Global compliance & oversight

Capabilities

Pharmacovigilance Capabilities

01
Clinical Safety Planning
02
Medical Monitoring
03
Aggregate & Periodic Support
04
Defined Interfaces
Section 01

Clinical Safety Planning

  • Safety management plan and responsibility matrix
  • Safety database and case workflow interfaces where applicable
  • Serious adverse event review and reconciliation support
  • Expedited reporting coordination according to assigned responsibilities
  • Safety communication and escalation pathways
Section 02

Medical Monitoring

Medical monitoring may include protocol and eligibility questions, review of relevant clinical and laboratory data, medical issue escalation, investigator support, and input to safety decisions according to the agreed medical monitoring plan.

Section 03

Aggregate and Periodic Support

Where included in scope, support may cover safety listings, trend review, aggregate report inputs, development safety update materials, and reconciliation with clinical and regulatory documents.

Section 04

Defined Interfaces

The safety model identifies the sponsor, investigator, medical monitor, pharmacovigilance provider, clinical team, data team, vendors, timelines, and reporting authority for each activity.

Partner With Globyz

Share the protocol or synopsis, product details, expected safety reporting timeline, and regulatory responsibilities to get started.